
NYSE:UNH
This summary was created by AI, based on 41 opinions in the last 12 months.
UnitedHealth Group Inc (UNH) is facing a period of volatility, with mixed opinions among experts about its future. While some see potential for recovery and growth, especially with improvements in fundamentals and a return of the previous CEO, others are wary due to regulatory challenges and high medical costs persisting in the U.S. healthcare market. Many analysts highlight the stock's recent downturn, attributing it to uncertainties including proposals from the Trump administration that could impact Medicare Advantage rates. Despite these challenges, several experts see value in the stock at current levels, indicating a possible turnaround as the company stabilizes its earnings and pricing strategies. However, caution is advised as many foresee a bumpy road ahead with potential regulatory scrutiny continuing to impact the business.
Largest “managed care” company in the US. This stock would benefit from higher interest rates as they would get to raise their rates as rates go up. Quarter was a blow out quarter and the stock has done nothing but go up higher ever since. Even at the current price, it is at about 13X earnings and could go to 15X giving the benefit of earnings growth. 1.5% yield.
Healthcare, as a group, tends to be one of the best performing parts of the market. This is because there is a heavy domestic focus on the US and also it is not so economically sensitive. There is a secular bull market in spending on health in the US. 90% of this company’s revenue is coming from premiums on the plans that they sell. 3%-7% growth. Yield of 1.64%. They have a platform called Optum (?), an information services platform that they used to generate fees across a number of different businesses. Cash flow grew at 16% last year and this year will be at 29% of revenues and by 2015 it will be 40% of their revenues.
(A Top Pick July 23/13. Up 18.88%.) There was a feeling they were going to get hurt by Obama care, but it wasn’t. Two weeks ago consensus was $126, and they reported $142 for the quarter, 2 quarters in a row of above-average growth. A nice safe place to hide and have exposure to the US healthcare.